Here are three highlights:
1. The patent covers “administering any spine deformation therapeutics to a patient having a spine deformation altered risk associated biomarker.”
2. This patent supports the company’s commercial use of their diagnostic and next-generation companion treatment products.
3. Predictive Technology Group currently has pending U.S. and international patent applications.
More articles on devices:
Coastal Orthopedics’ Dr. Gennady Gekht is 1st west coast Florida physician to use the Axium Neurostimulator System: 4 notes
Life Spine announces initial cases and multiple surgeries for LONGBOW™ Expandable Lateral Spacer System
FDA clears Spinal Elements’ line of expandable interbody devices: 5 notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
